Redirecting Immunity to fight Cancer with VerImmune's Dr. Joshua Wang
Description
Dr. Joshua Wang is currently the CEO and founder of VerImmune, a biotech company focused on developing novel virus inspired particle technology platform that can be used as a delivery system to target cancers.
In this episode, Josh shares his journey from having an interest in infectious diseases to leading a biotech startup that spans across the US and Singapore. VerImmune specializes in developing Virus-Inspired Particle (VIP) technology for targeting cancers. Josh discusses his academic background, including his PhD work at Johns Hopkins, and how serendipitous events led him from vaccine research to entrepreneurship. He explains the mechanics and advantages of VerImmune's VIP technology, its application in cancer treatment, and its potential for other therapeutic areas. The episode also covers challenges in biotech entrepreneurship, the importance of manufacturing and scalability, and the strategic decisions behind relocating some operations to Singapore. Dr. Wang offers valuable advice for aspiring biotech founders, emphasizing the significance of discernment, persistence, and leveraging global opportunities.
Host: Dillon Chew
Editors: Hana Maldivita Tambrin, Aakash S/O Naresh Kumar, Dillon Chew, John Joson Ng
00:00 Josh's Background and Early Career
05:13 Founding his first Startup
06:27 Challenges in the Vaccine Business
07:46 VerImmune and their VIP Technology
21:24 Collaborations and Global Expansion
29:48 Advice for Aspiring Bioentrepreneurs
32:38 Conclusion and Final Thoughts
United States
